These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14736986)

  • 21. [Automated peritoneal dialysis: impact on residual kidney function and peritoneal membrane permeability].
    Gallar P; Ortega O; Gutiérrez M; Carreño A; Domínguez-Gil B; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2001; 21(2):200-3. PubMed ID: 11464654
    [No Abstract]   [Full Text] [Related]  

  • 22. Crystal-induced inflammation associated with chronic renal failure treated with periodic hemodialysis.
    Moskowitz RW; Vertes V; Schwartz A; Marshall G; Friedman B
    Am J Med; 1969 Sep; 47(3):450-60. PubMed ID: 5808658
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of peritoneal dialysis on patient and graft outcome after kidney transplantation.
    Lameire N; Van Biesen W; Vanholder R
    Contrib Nephrol; 2003; (140):226-41. PubMed ID: 12800364
    [No Abstract]   [Full Text] [Related]  

  • 24. Compression of the anterior mediastinum by uremic tumoral calcinosis unusually involving the sternoclavicular joint.
    Sohn MH; Kim MW; Lim ST; Yim HY; Lee S; Kim W; Park SK; Yim CY
    Clin Nucl Med; 2005 Mar; 30(3):196-8. PubMed ID: 15722829
    [No Abstract]   [Full Text] [Related]  

  • 25. [Life-threatening hypoglycemia in uremia].
    Oren S; Rapaport J; Haimovitz C
    Harefuah; 1987 Feb; 112(4):171-3. PubMed ID: 3609937
    [No Abstract]   [Full Text] [Related]  

  • 26. Giant calcified mass in a hemodialysis patient.
    Combalia A; Munoz-Mahamud E; Cofan F
    Kidney Int; 2019 Mar; 95(3):719. PubMed ID: 30784665
    [No Abstract]   [Full Text] [Related]  

  • 27. Invasive uraemic calcinosis of the hip.
    Gibson C; Robbins P; Guy S
    Clin Radiol; 2009 Oct; 64(10):1035-6. PubMed ID: 19748010
    [No Abstract]   [Full Text] [Related]  

  • 28. [Posttransplant regression of uremic tumoral calcinosis].
    de Alarcón RM; Palomares M; Marfil A; Asensio C
    Nefrologia; 2007; 27(3):378-81. PubMed ID: 17725459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What unique acid-base considerations exist in dialysis patients?
    Oh MS; Uribarri J; Weinstein J; Schreiber M; Kamel KS; Kraut JA; Madias NE; Laski ME
    Semin Dial; 2004; 17(5):351-64. PubMed ID: 15461741
    [No Abstract]   [Full Text] [Related]  

  • 30. New-onset psoriasis during peritoneal dialysis.
    Geerse DA; Suijkerbuijk J; van Poppelen KM; Litjens EJ; Cornelis T
    Perit Dial Int; 2014; 34(7):802-3. PubMed ID: 25520486
    [No Abstract]   [Full Text] [Related]  

  • 31. Diet and infrequent peritoneal dialysis in chronic anuric uremia.
    Levin S; Winkelstein JA
    N Engl J Med; 1967 Sep; 277(12):619-24. PubMed ID: 4378226
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal osteodystrophy presenting with multiple calcified periarticular swellings.
    Ashine S; Admassie D
    Ethiop Med J; 2002 Jul; 40(3):293-301. PubMed ID: 12602253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A conservative approach to peritoneal dialysis-associated rectocele.
    Lew SQ; Robinson JK
    Perit Dial Int; 2014; 34(6):655-7. PubMed ID: 25228215
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tumor calcinosis in chronic renal insufficiency].
    Caballero P; Reyes R; Quirós J; Macarrón P; Lara T
    Rev Clin Esp; 1986 Jul; 179(3):138-41. PubMed ID: 3763993
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 37. [Essential amino acids supplementation therapy in uremic patients with regular dialysis treatment].
    Ando A
    Nihon Rinsho; 1991 Dec; 49 Suppl():775-80. PubMed ID: 1808349
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature.
    Tziviskou E; Musso C; Bellizzi V; Khandelwal M; Wang T; Savaj S; Oreopoulos DG
    Int Urol Nephrol; 2003; 35(3):429-34. PubMed ID: 15160552
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumoral calcinosis in an end stage kidney disease patient on peritoneal dialysis.
    Sankar L; Norfolk E; Kalra K
    Am J Med Sci; 2024 Mar; 367(3):e27-e28. PubMed ID: 37844731
    [No Abstract]   [Full Text] [Related]  

  • 40. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits.
    Hamada J; Tamai K; Ono W; Saotome K
    J Rheumatol; 2006 Jan; 33(1):119-26. PubMed ID: 16395759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.